Skip to main content

Advertisement

Log in

Changes in trends over time for the specific contribution of different risk factors for pre-eclampsia

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

The prevalence of risk factors for pre-eclampsia has changed over time; however, little is known regarding how these changes have altered the specific contribution of each risk factor. We aim to identify trends in the contribution of different risk factors throughout different time intervals.

Methods

We compared the prevalence and odds-ratio of different known risk factors for pre-eclampsia occurring in three equal population groups from 1988 to 2014. Data was retrieved from our medical center's perinatal database. A multivariable logistic regression model was employed to identify independent risk factors for pre-eclampsia. We evaluated changes in risk factors and their specific contribution to the occurrence of pre-eclampsia over time and a comparison of the prevalence and odds-ratios of chosen risk factors between the three time periods was performed.

Results

295,946 pregnancies met the inclusion criteria; of those, 16,246 (5.5%) were complicated with pre-eclampsia with the incidence increasing from 8 to 11%. Chronic hypertension, systemic lupus erythematosus, pre-gestational diabetes mellitus, twin pregnancy, advanced maternal age and fertility treatments were found to be the strongest independent risk factors. While rates of twin pregnancies and pre-gestational diabetes mellitus have demonstrated a linear increase, fertility treatments demonstrated a linear decrease. Chronic hypertension and systemic lupus erythematosus resulted in a mixed trend.

Conclusion

In our study, not only did the rates of different risk factors for pre-eclampsia change over the study period, the specific contribution of each risk factor for the occurrence of pre-eclampsia changed as well. Developing a better understanding of these trends might aid in our ability to predict this major complication and to improve maternal and fetal outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J et al (2014) Global causes of maternal death: a WHO systematic analysis. Lancet Glob Heal 2(6):323–333

    Article  Google Scholar 

  2. Roberts JM, August PA, George Bakris JRB (2012) Hypertension in pregnancy. Cardiol Clin 30(3):407–423. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24150027%5Cn, http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006250-201311000-00036. Accessed 19 Nov 2019

  3. Umesawa M, Kobashi G (2017) Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res 40(3):213–220. https://doi.org/10.1038/hr.2016.126 (Internet)

    Article  PubMed  Google Scholar 

  4. Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY (2014) Preeclampsia: an update. Acta Anaesthesiol Belg 65(4):137–149

    CAS  PubMed  Google Scholar 

  5. Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, Varner MW, et al. First-Trimester Prediction of Preeclampsia in Low-Risk Nulliparous Women. Obstet Gynecol. 2012 Jun; 119 (6):1234–42. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360523/

  6. North RA, McCowan LME, Dekker GA, Poston L, Chan EHY, Stewart AW, et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ. 342:d1875. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072235/2011 Apr 7

  7. Yusuf AM, Kahane A, Ray JG (2017) First and second trimester serum sFlt-1/PlGF ratio and subsequent preeclampsia: a systematic review. J Obstet Gynaecol Canada. https://doi.org/10.1016/j.jogc.2017.07.014 (Internet)

    Article  Google Scholar 

  8. Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH (2013) Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 33(1):8–15

    Article  Google Scholar 

  9. Bartsch E, Medcalf KE, Park AL, Ray JG, Al-Rubaie ZTA, Askie LM, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies. BMJ. 353:i1753. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837230/ 2016 Apr 19

  10. Viguiliouk E, Park AL, Berger H, Geary MP, Ray JG (2017) A simple clinical method to identify women at higher risk of preeclampsia. Pregnancy Hypertens 10:10–13

    Article  Google Scholar 

  11. Bm E, Zhao Y, Axon R (2010) Us trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 303(20):2043–2050. https://doi.org/10.1001/jama.2010.650 (Internet)

    Article  Google Scholar 

  12. Ls G, Wang J, YJ C et al (2014) Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA 312(12):1218–1226. https://doi.org/10.1001/jama.2014.11494 (Internet)

    Article  CAS  Google Scholar 

  13. GBD 2015 Obesity Collaborators (2017) Health effects of overweight and obesity in 195 countries over 25 years. New Eng J Med 377(1):13–27

    Article  Google Scholar 

  14. American Lung Association (2011) Research and program services epidemiology and statistics unit. Trends in tobacco use

  15. Hutcheon JA, Lisonkova S, Joseph KS (2011) Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 25(4):391–403. https://doi.org/10.1016/j.bpobgyn.2011.01.006

    Article  PubMed  Google Scholar 

  16. Wallis AB, Saftlas AF, Hsia J, Atrash HK (2008) Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens 21(5):521–526

    Article  Google Scholar 

  17. Lawrence JM, Contreras R, Chen W, Sacks Da (2008) Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women. Diabetes Care 31(5):899–904

    Article  Google Scholar 

  18. Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care. 2011 Jul; 41(6):158–76. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21684471. Accessed 19 Nov 2019

  19. Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP et al (2008) Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 198(4):428.e1–428.e6

    Article  Google Scholar 

  20. Arias E (2010) National vital statistics reports. National vital statistics reports, 58(21)

  21. Luke B, Brown MB. Contemporary risks of maternal morbidity and adverse outcomes with increasing maternal age and plurality. Fertil Steril. 2007/01/25. 2007 Aug; 88(2):283–93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17258214. Accessed 19 Nov 2019

  22. Dildy GA, Jackson GM, Fowers GK, Oshiro BT, Varner MW, Clark SL (1996) Very advanced maternal age: pregnancy after age 45. Am J Obstet Gynecol 175(3):668–674

    Article  CAS  Google Scholar 

  23. https://www.health.gov.il/PublicationsFiles/darom.pdf. Accessed 15 July 2019

  24. Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, De Paco MC et al (2018) Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. Obstet Gynecol Surv 73(1):11–12

    Article  Google Scholar 

Download references

Acknowledgements

We thank the women which participated in our study.

Funding

We did not receive any funding for this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

I declare that I participated in manuscript writing, data management and project development, and that I have seen and approved the final version. I have no following conflicts of interest: YS. I declare that I participated in manuscript writing, data management and project development and that I have seen and approved the final version. I have no following conflicts of interest: GP. I declare that I participated the project development, manuscript editing, and that I have seen and approved the final version. I have no following conflicts of interest: AW. I declare that I participated in protocol development, data analysis and manuscript editing, and that I have seen and approved the final version. I have no following conflicts of interest: RR. I declare that I participated in protocol development, data analysis and manuscript editing, and that I have seen and approved the final version. I have no following conflicts of interest: YB. I declare that I participated in the manuscript editing, and that I have seen and approved the final version. I have no following conflicts of interest: SM.

Corresponding author

Correspondence to Reut Rotem.

Ethics declarations

Conflict of interest

We declare that we have no conflict of interest.

Ethical approval

The study was approved by the Institutional Review Board in accordance with the Helsinki declaration (Protocol number SOR- 18- 0104).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shraga, Y., Pariente, G., Rotem, R. et al. Changes in trends over time for the specific contribution of different risk factors for pre-eclampsia. Arch Gynecol Obstet 302, 977–982 (2020). https://doi.org/10.1007/s00404-020-05693-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-020-05693-1

Keywords

Navigation